Skip to main content
. 2022 Oct 5;23(19):11810. doi: 10.3390/ijms231911810

Figure 5.

Figure 5

The levels of endocannabinoids (A): [N-arachidonoylethanolamine (AEA), 2-arachidonoylglycerol (2-AG)] and other bioactive acylethanolamides (B): [N-oleoylethanolamine (OEA), N-palmitoylethanolamine (PEA)] in the plasma of patients with COVID-19, including those who recovered (n = 66) and those who deceased (n = 22) as well as healthy subjects (n = 33). Data points represent the mean ± SD; a, significantly different from healthy subject, p < 0.05; b, significantly different from patients with COVID-19 recovered, p < 0.05.